Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13376
Cardiff Oncology
CRDF
$74.9M
| $11.6K | ﹤0.01% |
7,007
+1,291
| +23% | +$2.22K |
|
13377
Laird Superfood
LSF
$52.7M
| $11.6K | ﹤0.01% |
14,259
-3,381
| -19% | -$3.56K |
|
13378
CALL
Vanda Pharmaceuticals
VNDA
$316M
| $11.5K | ﹤0.01% |
1,700
-4,400
| -72% | -$30.9K |
|
13379
PUT
AvePoint
AVPT
$2.85B
| $11.5K | ﹤0.01% |
2,800
-15,100
| -84% | -$68.1K |
|
|
GHL
13380
PUT
DELISTED
Greenhill & Co., Inc.
GHL
| $11.5K | ﹤0.01% |
1,300
-1,800
| -58% | -$20.5K |
|
13381
PUT
CNB Financial Corp
CCNE
$1.03B
| $11.5K | ﹤0.01% |
600
+200
| +50% | +$4.57K |
|
13382
PUT
Ampco-Pittsburgh
AP
$194M
| $11.5K | ﹤0.01% |
4,700
+1,100
| +31% | +$3.14K |
|
|
RDNW
13383
PUT
RideNow Group
RDNW
$248M
| $11.5K | ﹤0.01% |
1,900
+600
| +46% | +$4.89K |
|
13384
CALL
Instil Bio
TIL
$50.1M
| $11.5K | ﹤0.01% |
870
+660
| +314% | +$9.75K |
|
13385
PUT
CytomX Therapeutics
CTMX
$732M
| $11.5K | ﹤0.01% |
7,600
+3,000
| +65% | +$6.78K |
|
13386
Ascent Solar Technologies
ASTI
$32.6M
| $11.4K | ﹤0.01% |
2
+1
| +100% | +$16.9K |
|
13387
PUT
Evogene
EVGN
$9.49M
| $11.4K | ﹤0.01% |
1,810
-220
| -11% | -$1.64K |
|
|
CHRN
13388
CALL
ChronoScale Holdings
CHRN
$3.04B
| $11.4K | ﹤0.01% |
460
+413
| +879% | +$9.76K |
|
13389
PUT
Farmers National Banc Corp
FMNB
$966M
| $11.4K | ﹤0.01% |
900
+400
| +80% | +$5.53K |
|
13390
PUT
TMC The Metals Company
TMC
$1.77B
| $11.3K | ﹤0.01% |
13,600
-49,300
| -78% | -$45.8K |
|
13391
CALL
First Financial Corp
THFF
$976M
| $11.2K | ﹤0.01% |
+300
| New | +$12.9K |
|
13392
CALL
Holley
HLLY
$377M
| $11.2K | ﹤0.01% |
4,100
+3,800
| +1,267% | +$9.71K |
|
|
AUUD
13393
Auddia
AUUD
$5.47M
| $11.2K | ﹤0.01% |
5
| – | – |
|
|
NSLR
13394
PUT
Neostellar Capital Corp
NSLR
$278M
| $11.2K | ﹤0.01% |
3,100
-56,542
| -95% | -$217K |
|
13395
PUT
System1
SST
$24.6M
| $11.2K | ﹤0.01% |
260
-8,360
| -97% | -$371K |
|
13396
CALL
First Trust Preferred Securities and Income ETF
FPE
$6.34B
| $11.2K | ﹤0.01% |
700
-1,400
| -67% | -$24.2K |
|
13397
PUT
Hanmi Financial
HAFC
$962M
| $11.1K | ﹤0.01% |
600
| – | – |
|
|
ISUN
13398
CALL
DELISTED
iSun, Inc. Common Stock
ISUN
| $11.1K | ﹤0.01% |
10,800
-4,800
| -31% | -$7.16K |
|
13399
REX American Resources
REX
$1.47B
| $11.1K | ﹤0.01% |
778
-57,696
| -99% | -$912K |
|
13400
CALL
Neuronetics
STIM
$230M
| $11.1K | ﹤0.01% |
3,800
-2,600
| -41% | -$13.1K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.